blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3129041

EP3129041 - DOUBLE-ACYLATED GLP-1 COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.04.2020
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  10.05.2019
FormerGrant of patent is intended
Status updated on  18.11.2018
FormerExamination is in progress
Status updated on  22.09.2017
FormerRequest for examination was made
Status updated on  13.01.2017
FormerThe international publication has been made
Status updated on  16.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2017/07]
Inventor(s)01 / LINDEROTH, Lars
Novo Allé
DK-2880 Bagsværd / DK
02 / KOFOED, Jacob
Novo Allé
DK-2880 Bagsværd / DK
03 / LAU, Jesper
Novo Allé
DK-2880 Bagsværd / DK
04 / BLOCH, Paw
Novo Allé
DK-2880 Bagsværd / DK
05 / GARIBAY, Patrick William
Novo Allé
DK-2880 Bagsværd / DK
06 / KODRA, János Tibor
Novo Allé
DK-2880 Bagsværd / DK
 [2017/07]
Application number, filing date15713772.007.04.2015
[2017/07]
WO2015EP57442
Priority number, dateEP2014016369707.04.2014         Original published format: EP 14163697
[2017/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015155151
Date:15.10.2015
Language:EN
[2015/41]
Type: A1 Application with search report 
No.:EP3129041
Date:15.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 15.10.2015 takes the place of the publication of the European patent application.
[2017/07]
Type: B1 Patent specification 
No.:EP3129041
Date:12.06.2019
Language:EN
[2019/24]
Search report(s)International search report - published on:EP15.10.2015
ClassificationIPC:A61K38/26, C07K14/605
[2017/07]
CPC:
C07K14/605 (EP,CN,US); A61P1/00 (EP); A61P15/08 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P5/48 (EP); A61P9/00 (EP);
C07C235/20 (US); C07C237/22 (CN); A61K38/00 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:ZWEIFACH ACYLIERTE GLP-1-VERBINDUNGEN[2017/07]
English:DOUBLE-ACYLATED GLP-1 COMPOUNDS[2017/07]
French:COMPOSÉS GLP-1 ACYLÉS DOUBLES[2018/38]
Former [2017/07]COMPOSÉS GLP -1 À DOUBLE ACYLATION
Entry into regional phase07.11.2016National basic fee paid 
07.11.2016Designation fee(s) paid 
07.11.2016Examination fee paid 
Examination procedure07.11.2016Examination requested  [2017/07]
07.11.2016Date on which the examining division has become responsible
23.05.2017Amendment by applicant (claims and/or description)
21.09.2017Despatch of a communication from the examining division (Time limit: M04)
23.01.2018Reply to a communication from the examining division
22.02.2018Despatch of a communication from the examining division (Time limit: M04)
04.06.2018Reply to a communication from the examining division
19.11.2018Communication of intention to grant the patent
15.03.2019Fee for grant paid
15.03.2019Fee for publishing/printing paid
15.03.2019Receipt of the translation of the claim(s)
Opposition(s)13.03.2020No opposition filed within time limit [2020/21]
Fees paidRenewal fee
02.05.2017Renewal fee patent year 03
30.04.2018Renewal fee patent year 04
30.04.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.04.2015
AL12.06.2019
AT12.06.2019
CY12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
MK12.06.2019
MT12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
[2022/32]
Former [2022/28]HU07.04.2015
AL12.06.2019
AT12.06.2019
CY12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
MT12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/52]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/36]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/24]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
IS24.02.2020
Former [2020/22]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/17]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/14]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/12]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/11]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
Former [2020/10]AL12.06.2019
AT12.06.2019
CZ12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
Former [2020/09]AL12.06.2019
CZ12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2020/07]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2019/51]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2019/50]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
RS12.06.2019
SE12.06.2019
NO12.09.2019
GR13.09.2019
Former [2019/49]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
SE12.06.2019
NO12.09.2019
Former [2019/48]FI12.06.2019
LT12.06.2019
SE12.06.2019
NO12.09.2019
Former [2019/47]FI12.06.2019
LT12.06.2019
NO12.09.2019
Cited inInternational search[Y]WO9808871  (NOVO NORDISK AS [DK], et al) [Y] 1-7,9-15 * the whole document *;
 [YD]US2006194720  (HAYASHI YUJI [JP], et al) [YD] 1-7,9-15 * the whole document *;
 [Y]US2011166321  (GARIBAY PATRICK WILLIAM [DK], et al) [Y] 1-7,9-15 * the whole document *;
 [Y]WO2012062803  (NOVO NORDISK AS [DK], et al) [Y] 1-7,9-15 * the whole document *;
 [Y]WO2012140117  (NOVO NORDISK AS [DK], et al) [Y] 1-7,9-15 * the whole document *;
 [YD]WO2013037690  (NOVO NORDISK AS [DK], et al) [YD] 1-7,9-15 * the whole document *;
 [YD]WO2013167455  (NOVO NORDISK AS [DK]) [YD] 1-7,9-15 * the whole document *;
 [Y]WO2013167454  (NOVO NORDISK AS [DK]) [Y] 1-7,9-15 * the whole document *;
 [A]US2014004198  (BALSCHMIDT PER [DK], et al) [A] 1-7,9-15 * the whole document *;
 [Y]  - KNUDSEN LOTTE B ET AL, "Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (20000504), vol. 43, no. 9, doi:10.1021/JM9909645, ISSN 0022-2623, pages 1664 - 1669, XP002201014 [Y] 1-7,9-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm9909645
 [A]  - WEIPING TANG ET AL, "Discovery of histone deacetylase 8 selective inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20110501), vol. 21, no. 9, doi:10.1016/j.bmcl.2011.01.134, ISSN 0960-894X, pages 2601 - 2605, XP055188885 [A] 11,12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2011.01.134
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.